Unusual bevacizumab-related complication of an oral infection

Journal of Oral and Maxillofacial Surgery

Volumn 71, Issue 1, 2013, Pages 53-55

  Magremanne, Michèle ^a   Lahon, Morgan ^b   De Ceulaer, Joke ^a   Reychler, Hervé ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Centre Hospitalier Universitaire Ambroise Pare   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CHLORHEXIDINE; CLINDAMYCIN; CORTICOSTEROID; MEROPENEM; TEMOZOLOMIDE;

ADULT; ARTICLE; BACTERIAL INFECTION; BRAIN DECOMPRESSION; BRAIN HERNIA; CANCER RADIOTHERAPY; CASE REPORT; CELLULITIS; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; ENTEROBACTER CLOACAE; GLIOBLASTOMA; HEALING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOUTH ABSCESS; MOUTH INFECTION; PANORAMIC RADIOGRAPHY; SOFT TISSUE INFECTION; STAPHYLOCOCCUS XYLOSUS; SWELLING; TEMPORAL LOBE GLIOBLASTOMA; TOOTH INFECTION; TOOTH PAIN;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BRAIN NEOPLASMS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; FACE; FATAL OUTCOME; GLIOBLASTOMA; HUMANS; MALE; MANDIBULAR NERVE; MIDDLE AGED; NECROSIS; PERIODONTAL ABSCESS; RECOMBINANT PROTEINS; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; TEMPORAL LOBE;

EID: 84871225112     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2012.03.022     Document Type: Article

References (15)

1. C.L. Estilo, M. Fornier, A. Farooki Osteonecrosis of the jaw related to bevacizumab J Clin Oncol 26 2008 4037
2. F. Greuter, F. Schmid, T. Ruhstaller Bevacizumab-associated osteonecrosis of the jaw Ann Oncol 19 2008 2091
3. E. Serra, M. Paolantonio, G. Spoto Bevacizumab-related osteonecrosis of the jaw Int J Immunopathol Pharmacol 22 2009 1121
4. U. Dişel, A.A. Beşen, O. Ozylkan A case report of bevacizumab-related osteonecrosis of the jaw: Old problem, new culprit Oral Oncol 48 2012 e2
5. R.N. Hopp, J. Pucci, A.R. Santos-Silva Osteonecrosis after administration of intravitreous bevacizumab J Oral Maxillofac Surg 70 2012 632
6. D.M. Hartl, R. Bahleda, A. Hollebecque Bevacizumab-induced laryngeal necrosis Ann Oncol 23 2012 276
7. A. Mailliez, C. Baldini, J.T. Van Nasal septum perforation: A side effect of bevacizumab chemotherapy in breast cancer patients Br J Cancer 103 2010 772
8. V. Guarneri, D. Miles, N. Robert Bevacizumab and osteonecrosis of the jaw: Incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer Breast Cancer Res Treat 122 2010 181
9. H. Hurwitz, L. Fehrenbacher, W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335
10. F.A. Scappaticci, L. Fehrenbacher, T. Cartwright Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab J Surg Oncol 91 2005 173
11. J.P. Erinjeri, A.J. Fong, N.E. Kemeny Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement Cancer 117 2011 1296
12. I. Kriegel, P.H. Cottu, V. Fourchotte Wound healing and catheter thrombosis after implantable venous access device placement in 266 breast cancers treated with bevacizumab therapy Anticancer Drugs 22 2011 1020
13. A. Garant, S. Des Groseilliers, L. Martin Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer Clin Oncol (R Coll Radiol) 23 2011 492
14. D. Hompes, T. Ruers Review: Incidence and clinical significance of bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer Eur J Surg Oncol 37 2011 737
15. F. Kazazi-Hyseni, J.H. Beijnen, J.H. Schellens Bevacizumab Oncologist 15 2010 819